Bio Pharma Dive
AUGUST 15, 2024
The agency said the first round of pricing talks, which involved drugs like the blood thinners Eliquis and Xarelto, will result in $6 billion in savings for taxpayers.
Pharmaceutical Technology
AUGUST 15, 2024
Strong measures must be in place to safeguard confidential patient data when deploying AI to optimise clinical trial translations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
AUGUST 15, 2024
The layoffs are part of a larger reorganization that will also see the departure of Lykos’ founder, the psychedelics advocate Rick Doblin.
Pharmaceutical Technology
AUGUST 15, 2024
Livdelzi is said to be effective against primary biliary cholangitis (PBC) for patients unresponsive to standard-of-care therapy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
AUGUST 15, 2024
The approval of Niktimvo in graft-versus-host disease hands Incyte another immune system-regulating medicine that analysts see as valuable, especially if use is broadened through additional clearances.
Pharmaceutical Technology
AUGUST 15, 2024
Evotec’s CEO Christian Wojczewski had previously announced a strategic reset after shutting down its gene therapy business earlier this year.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
AUGUST 15, 2024
Clinical trials for the two RNA interference (RNAi) programmes are slated to commence in early 2025.
Fierce Pharma
AUGUST 15, 2024
Just as a new strain of mpox spreads across Africa, results from a preliminary analysis of a study that began during the 2022 viral outbreak stands to provide more clarity on the clinical benefit o | Despite missing the trial's primary endpoint of time to lesion resolution, the study suggested that the treatment may be most beneficial for those treated early and those with severe disease.
Pharmaceutical Technology
AUGUST 15, 2024
The anti-CSF1R antibody, Nikitimvo, has been approved as a third-line treatment for chronic graft-versus-host disease (GvHD).
Fierce Pharma
AUGUST 15, 2024
Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the | Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the original lawsuit.
pharmaphorum
AUGUST 15, 2024
AI's role in inventing new drugs raises questions about ownership rights in the pharmaceutical sector. Explore the complexities of defining ownership in drug discovery with AI technology.
Pharma Times
AUGUST 15, 2024
Children accounted for the majority of mpox cases and deaths in the DRC since June 2023
pharmaphorum
AUGUST 15, 2024
AstraZeneca's plan to invest £450m in a vaccines plant in the UK has been thrown into doubt by a bid to slash state aid, reports FT
Fierce Pharma
AUGUST 15, 2024
So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. | So far in August, the FDA has announced two separate drug recalls on its website: one related to particulate concerns and the other thanks to high endotoxin levels. While neither recall has resulted in any safety flags or side effect reports so far, the issues stemming from the faulty products could be severe, the drugmakers have w
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
AUGUST 15, 2024
FDA clears Incyte's potential blockbuster Niktimvo as a treatment for chronic GvHD, making it a companion to the company's Jakafi for the disorder.
Outsourcing Pharma
AUGUST 15, 2024
Tonix Pharmaceuticals has announced promising phase 3 trial results for TNX-102 SL (sublingual cyclobenzaprine HCl), a treatment targeting fibromyalgia.
pharmaphorum
AUGUST 15, 2024
Large language models (LLMs) find it hard to identify genetic conditions based on patient-written descriptions, say NIH researchers.
Pharma Times
AUGUST 15, 2024
Combined, Crohn’s disease and ulcerative colitis affect over 500,000 people in the UK
pharmaphorum
AUGUST 15, 2024
FDA approves Gilead's Livdelzi for primary biliary cholangitis, setting up a contest with Ipsen's recent launch Iqirvo in the second-line setting
Rethinking Clinical Trials
AUGUST 15, 2024
The Chronic Pain and Fatigue Research Center at the University of Michigan is requesting applications for the HEAL National K12 Clinical Pain Career Development Award (HEAL K12). The HEAL K12 is a mentored career development program designed to provide protected time for clinicians and scientists to focus on training in and conducting clinical pain research.
Fierce Pharma
AUGUST 15, 2024
The clinical operations and trial management community is buzzing with anticipation as the most influential leaders in the field prepare to convene at the
Outsourcing Pharma
AUGUST 15, 2024
Lonza, a global leader in the pharmaceutical, biotech, and nutraceutical markets, has announced a significant expansion of its clinical manufacturing services at its small molecules site in Bend, Oregon.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioPharma Reporter
AUGUST 15, 2024
Katarina Wikstrom has worked for over 20 years in the field of translational molecular oncology and holds the position of VP global product development at Almac Diagnostic Services.
pharmaphorum
AUGUST 15, 2024
A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales.
Fierce Pharma
AUGUST 15, 2024
The TROP2 antibody-drug conjugate race has heated up among three Big Pharma companies: Gi | In this week’s episode of “The Top Line,” Fierce executive editor Eric Sagonowsky chats with Angus Liu about his feature story on the three TROP2 front-runners.
Pharmaceutical Commerce
AUGUST 15, 2024
Partnership adds supply chain efficiencies, while prioritizing patient safety.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
AUGUST 15, 2024
Recently, two leading and long-established firms in the expanding AI drug discovery sector revealed an unexpected merger. In an approximate 75-25 agreement, Recursion Bio and Exscientia are set to unite, pending approval, into a single entity that will merge Recursion's biological proficiency with Exscientia's chemical specialisation.
Intouch Solutions
AUGUST 15, 2024
In the ever-evolving landscape of healthcare marketing, understanding audience engagement and measuring success is paramount. In a recent PM360 Think Tank article , Iyiola Obayomi, SVP, Managing Director of Analytics, shared his expertise on mastering metrics. Let’s explore key insights from his perspective. Audience-Centric Metrics: Historically, marketers relied on superficial metrics like likes and shares.
Drug Patent Watch
AUGUST 15, 2024
This chart shows the drugs with the most patents in European Patent Office. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
BioPharma Reporter
AUGUST 15, 2024
Gilead wins on new company acquisition with accelerated approval for autoimmune liver disease drug
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
306 
Let's personalize your content